tiotropium bromide


Also found in: Dictionary, Wikipedia.
Related to tiotropium bromide: Tiotropium bromide monohydrate

tiotropium bromide

(tī′ō-trō′pē-əm)
n.
An anticholinergic compound used as an inhalant in the treatment of chronic obstructive pulmonary disease.

tiotropium bromide

A long-acting muscarinic receptor antagonist used to treat chronic obstructive pulmonay disease (COPD). A brand name is Spiriva.
Mentioned in ?
References in periodicals archive ?
Tiotropium bromide is contraindicated in patients with a known hypersensitivity to it, atropine, or its derivatives (including ipratropium), and as per other anticholinergic medications, tiotropium should be used with caution in patients with narrow-angle glaucoma or urinary retention [48].
Written and verbal instructions were provided to the patient to continue all medications at home, including her hydrochlorothiazide (HCTZ) 50 mg PO daily, Lasix 40 mg PO daily, lisinopril 20 mg PO daily, metoprolol succinate 100 mg PO daily (The Joint Commission, 2013), tiotropium bromide 18 meg capsule inhaled once daily, and Klor-Con[R] 40 mEq PO daily.
The first thing to do is to check if you are using an inhaler which has Salmeterol, Formoterol or Tiotropium bromide as the only active ingredient.
According to the study, adding tiotropium bromide to low doses of inhaled corticosteroids is more effective at controlling asthma than doubling inhaled corticosteroids alone, and as effective as adding the long-acting beta agonist salmeterol.
The purpose of which was to evaluate the RCC recommendations of tiotropium bromide inhalation powder (TB).
During follow-up from 6 weeks to 5 years, cardiovascular death, MI, or stroke occurred in 135 of 7,472 patients (1.8%) re ceiving either inhaled tiotropium bromide or ipratropium bromide for more than 30 days, compared with 86 of 7,311 patients (1.2%) receiving control therapy (relative risk 1.58).
Tiotropium bromide (Spiriva), a muscarinic receptor antagonist, is a long-acting bronchodilator.
PUR0200 combines tiotropium bromide, the active component in the drug Spiriva, with Pulmatrix's innovative iSPERSE drug delivery platform.
The trial also met its primary bronchodilation endpoint, demonstrating non-inferiority to tiotropium bromide once-daily.